B7-2 positive cells around interlobular bile ducts in primary biliary cirrhosis and chronic hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 7, 1997, Pages 507-512

  Kaji, Kyosuke ^a   Tsuneyama, Koichi ^a   Nakanuma, Yasuni ^a   Harada, Ken Ichi ^a   Sasaki, Motoko ^a   Kaneko, Shuichi ^a   Kobayashi, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

B7 2 positive cells; Chronic hepatitis C; Costimulatory factor; Interlobular bile duct; Primary biliary cirrhosis

Indexed keywords

CD28 ANTIGEN; CELL ADHESION MOLECULE;

ANTIGEN PRESENTATION; ARTICLE; BILE DUCT INJURY; BILIARY CIRRHOSIS; CHOLANGITIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030839130     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00474.x     Document Type: Article

References (33)

1. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15: 567-71.
2. Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Wiesner RH. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. Liver 1984; 4: 105-16.
3. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15: 572-7.
4. Gerber MA, Krawczynski K, Alter MJ, Sampliner RE, Margolis HS. Histopathology of community acquired chronic hepatitis C. The Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team. Mod. Pathol. 1992; 5: 483-6.
5. Lefkowitch JH, Schiff ER, Davis GL at al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993; 104: 595-603.
6. Mosnier JF, Degott C, Marcellin P, Henin D, Erlinger S, Benhamou JP. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology 1993; 17: 366-71.
7. Nakanuma Y, Tsuneyama K, Gershwin ME, Yasoshima M. Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress. Semin. Liver Dis. 1995; 15: 313-28.
8. Demetris AJ, Sever C, Kakizoe S, Oguma S, Starzl TE, Jaffe R. S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis? Am. J. Pathol. 1989; 134: 741-7.
9. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970; 169: 1042-9.
10. Lafferty KJ, Gill RG. The maintenance of self-tolerance. Immunol. Cell Biol. 1993; 209-14.
11. Liu Y, Linsley PS. Costimulation of T-cell growth. Curr. Opin. Immunol. 1992; 4: 265-70.
12. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol. Today 1994; 15: 321-31.
13. Freeman GJ, Borriello F, Hodes RJ et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 1993; 262: 907-9.
14. Lenschow DJ, Su GH, Zuckerman LA et al. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl Acad. Sci. USA 1993; 90: 11 054-8.
15. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 1994; 180: 631-40.
16. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994; 1: 327-39.
17. Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995; 2: 555-9.
18. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29: 577-80.
19. von Wasielewski R, Werner M, Nolte M, Wilkens L, Georgii A. Effects of antigen retrieval by microwave heating in formalin-fixed tissue sections on a broad panel of antibodies. Histochemistry 1994; 102: 165-72.
20. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274-8.
21. Scheuer PJ. Liver biopsy interpretation. London: Bailliére Tindall, 1980.
22. Torii T, Takahashi A, Dohi K. Statistics for medicine and biology Tokyo: Tokyo University Press, 1973 (in Japanese).
23. Kaji K, Nakanuma Y, Sasaki M et al. Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. Mod. Pathol. 1994; 7: 937-45.
24. Van de Water J, Turchany J, Leung PS et al. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J. Clin. Invest. 1993; 91: 2653-64.
25. Joplin R, Lindsay JG, Hubscher SG et al. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology 1991; 14: 442-7.
26. van den Oord JJ, Fevery J, de Groot J Desmet VJ. Immunohistochemical characterization of inflammatory infiltrates in primary biliary cirrhosis. Liver 1984; 4: 264-74.
27. Si L, Whiteside TL, Schade RR, Starzl TE, Van TD. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. J. Clin. Immunol. 1984; 4: 262-72.
28. Rontogianni D, Gerber H, Zimmermann A. Primary biliary cirrhosis (PBC): antigen-presenting cells differ in their distribution in early and late stage PBC and involve the ductal, but not the ductular compartment. Histol. Histopathol. 1994; 9: 211-20.
29. Steinman RM. Dendritic cells. Transplantation 1981; 31: 151-5.
30. Leon MP, Kirby JA, Gibbs P, Burt AD, Bassendine MF. Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J. Hepatol. 1995; 22: 591-5.
31. Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984; 2: 1009-13.
32. Nakanuma Y, Kono N. Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: an immunohistochemical study. Hum. Pathol. 1991; 22: 431-6.
33. Van den Oord JJ, Sciot R, Desmet VJ. Expression of MHC products by normal and abnormal bile duct epithelium. J. Hepatol. 1986; 3: 310-7.